Intelligent

Baidu Acquires JOYY's Live Streaming Business in China

BEIJING,Feb. 25,2025-- Baidu,Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"),a leading AI company with strong Internet foundation,today announced that Baid

02-26

Ascenda and Galileo Financial Technologies Collaborate to Elevate Card Loyalty Programs

Partnership combines Galileo\'s technology platform andAscenda\'s loyalty expertise to simplify and power card loyalty programs

02-26

Cedro Participações signs concession contract for the Port of Itaguaí at an event with President Lula and Minister Silvio Costa Filho

The company will be the first 100% Brazilian mining company to verticalize its operations and intends to invest R$3.6 billion in the project

02-26

The 2025 Wynn Signature Chinese Wine Awards Judging Week Commences at the End of February

The 6-day event features higher competition standards with an elevated panel of 27 acclaimed judges,plus a series of events including wine seminars,Masterclasses,and wine dinners

02-26 Wynn Resorts (Macau)

GILF Shortlisted in Catalog of Guangdong's Nationwide Trade Initiative (2025), Starting New Procurement Season in March

ZHONGSHAN,China,Feb. 25,2025-- Recently,the official website of the Department of Commerce of Guangdong Province released the Catalog of Guangdong\'s Nationwide Trade Initiative (2025). After submissi

02-26 China (Guzhen) International Lighting Fair

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c

02-26 Akeso, Inc.

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr

02-26 YolTech Therapeutics

Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25,2025 GUANGZHOU,China,Feb. 25,2025--Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG),a leading

02-26 Yatsen Holding Limited

Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android

Enables Users to Boost Productivity with AI-Powered Summaries,Cross-Document Insights,and Instant Data Extraction Across Mobile Device

02-26 Foxit

Vialto Partners Completes Recapitalization Transaction

Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of

02-26 Vialto Partners